Pegaspargase
Pegaspargase | |
---|---|
Term | Pegaspargase |
Short definition | Pegaspargase - (pronounced) (peg-a-spar-jays) medicine used with other medicines to treat adults and children with acute lymphoblastic leukaemia. It is used in patients whose cancer has not yet been treated or who cannot be treated with asparaginase. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Pegaspargase - (pronounced) (peg-a-spar-jays) medicine used with other medicines to treat adults and children with acute lymphoblastic leukaemia. It is used in patients whose cancer has not yet been treated or who cannot be treated with asparaginase. It is also being studied in the treatment of other types of cancer. Pegaspargase consists of the enzyme L-asparaginase linked to a substance called PEG, which allows the drug to stay in the body longer. L-asparaginase comes from the bacterium E. coli and breaks down the amino acid asparagine. This can stop the growth of cancer cells that need asparagine to grow. Pegaspargase is a type of protein synthesis inhibitor. Also called Oncaspar and PEG-asparaginase
External links
- Medical encyclopedia article on Pegaspargase
- Wikipedia's article - Pegaspargase
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski